Bristol-Myers Squibb Co. (BMY) PT Raised to $70 at Jefferies: SUCCESSOR-2 interim validates CELMoD strategy

Go back to Bristol-Myers Squibb Co. (BMY) PT Raised to $70 at Jefferies: SUCCESSOR-2 interim validates CELMoD strategy
Bristol-Myers Squibb (NYSE: BMY) Delayed: 59.12 -0.46 (0.77%)
Previous Close $59.58    52 Week High $77.12 
Open $58.88    52 Week Low $49.03 
Day High $59.79    P/E 38.39 
Day Low $58.74    EPS $1.54 
Volume 9,253,469